<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="42026">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02559245</url>
  </required_header>
  <id_info>
    <org_study_id>makan.pourmasoumi@gmail.com</org_study_id>
    <nct_id>NCT02559245</nct_id>
  </id_info>
  <brief_title>Comparison and Assessment of Effects of Flixweed and Fig on Irritable Bowel Syndrome With Predominant Constipation and Gastrointestinal Function: Single Blind Randomized Parallel Trial</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Isfahan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Isfahan University of Medical Sciences</source>
  <brief_summary>
    <textblock>
      This study evaluates effect of Ficus carica and Descurainia Sophia on irritable bowel
      syndrome predominant constipation. Half of patients receive Ficus carica while others
      receive Descurainia Sophia for 4 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>irritable bowel syndrome constipation predominant symptom</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Irritable Bowel Syndrome Predominant Constipation</condition>
  <arm_group>
    <arm_group_label>Ficus carica</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>45 grams Ficus carica before breakfast and lunch with 1 glass of water every day respectively (total consumption: Ficus carica 90g/d)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Descurainia Sophia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 grams Descurainia Sophia before breakfast and lunch with 1 glass of water every day respectively (total consumption: Descurainia Sophia 60g/d)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Descurainia Sophia</intervention_name>
    <arm_group_label>Descurainia Sophia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ficus carica</intervention_name>
    <arm_group_label>Ficus carica</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control</intervention_name>
    <description>a group with usual dietary pattern</description>
    <arm_group_label>Ficus carica</arm_group_label>
    <arm_group_label>Descurainia Sophia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with irritable bowel syndrome predominant constipation

        Exclusion Criteria:

          -  Subjects with significant cardiovascular, renal, hepatic, pulmonary, endocrine,
             metabolic, hematologic disorders,

          -  structural abnormalities of the gastrointestinal tract or

          -  diseases ‚ÅÑconditions that affected bowel transition,

          -  surgery,

          -  any prokinetic or laxative drug used during the past month,

          -  any medication that may affect gastrointestinal motility,

          -  other therapeutic dietary advice for IBS,

          -  used Fig or Flixweed during the last month,

          -  diarrhea,

          -  pregnancy or

          -  breast-feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Gastrointestinal Research Center</name>
      <address>
        <city>Isfahan</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 11, 2016</lastchanged_date>
  <firstreceived_date>September 21, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Isfahan University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Makan Pourmasoumi</investigator_full_name>
    <investigator_title>MSc Student, Food Security Research Center, Department of Community nutrition, School of Nutrition &amp; Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Constipation</mesh_term>
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
